SEC Sues Exec For Trading On 2016 Pfizer Merger News
The U.S. Securities and Exchange Commission filed an insider trading case Tuesday that claims a former Medivation Inc. executive bought stock options in a rival biopharmaceutical company "within minutes" of learning...To view the full article, register now.
Already a subscriber? Click here to view full article